MYD88 and cancer: reported that MYD88 signaling in activated myofibroblasts in colitis-associated cancer mouse model increases the secretion of osteopontin (OPN) to promote M2 polarization via binding to αvβ3 and CD44 and activating the STAT3/PPARγ pathway (47).